顔写真

PHOTO

Nishikawa Tomoyuki
西川 智之
Nishikawa Tomoyuki
西川 智之
Graduate School of Medicine,Specially Appointed Associate Professor (Full Time)

keyword Gene Therapy Science

Education 3

  1. Osaka University

    - 2006/04

  2. ニューヨーク大学大学院 生物科学研究科 応用DNA組み換え技術

    - 2000

  3. フィラデルフィア大学 生化学部

    - 1997

Committee Memberships 1

  1. 日本遺伝子細胞治療学会 評議員 Academic society

    2021/09 - Present

Professional Memberships 5

  1. ヨーロッパ遺伝子細胞治療学会

  2. アメリカ遺伝子細胞治療学会

  3. 日本がん免疫学会

  4. 日本癌学会

  5. 日本遺伝子細胞治療学会

Research Areas 2

  1. Life sciences / Biomaterials /

  2. Life sciences / Biomedical engineering /

Awards 3

  1. 研究奨励賞

    西川智之 日本遺伝子細胞治療学会 2015/05

  2. 若手奨励賞

    西川智之 日本遺伝子細胞治療学会 2006/07

  3. Outstanding Paper in Separation Science

    Tomoyuki Nishikawa American Chemical Society 1997/05

Papers 33

  1. Immunogenic Comparison of Nucleic Acid-Based Vaccines Administered by Pyro-Drive Jet Injector

    Jiayu A. Tai, Tomoyuki Nishikawa, Hiroki Hayashi, Yu-Diao Kuan, Kunihiko Yamashita, Hironori Nakagami

    Vaccines Vol. 12 No. 7 p. 757-757 2024/07/09 Research paper (scientific journal)

    Publisher: MDPI AG
  2. Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction

    Hiroki Hayashi, Jiao Sun, Yuka Yanagida, Takako Otera, Jiayu A. Tai, Tomoyuki Nishikawa, Kunihiko Yamashita, Naoki Sakaguchi, Shota Yoshida, Satoshi Baba, Chin Yang Chang, Munehisa Shimamura, Sachiko Okamoto, Yasunori Amaishi, Hideto Chono, Junichi Mineno, Hiromi Rakugi, Ryuichi Morishita, Hironori Nakagami

    Scientific Reports Vol. 13 No. 1 2023/08/10 Research paper (scientific journal)

    Publisher: Springer Science and Business Media LLC
  3. Enhancement of polyethylene glycol‐cell fusion efficiency by novel application of transient pressure using a jet injector

    Chin Yang Chang, Jiayu A. Tai, Yuko Sakaguchi, Tomoyuki Nishikawa, Yayoi Hirayama, Kunihiko Yamashita

    FEBS Open Bio Vol. 13 No. 3 p. 478-489 2023/01/27 Research paper (scientific journal)

    Publisher: Wiley
  4. Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant

    Hiroki Hayashi, Jiao Sun, Yuka Yanagida, Takako Otera, Miwa Sasai, Chin Yang Chang, Jiayu A. Tai, Tomoyuki Nishikawa, Kunihiko Yamashita, Naoki Sakaguchi, Shota Yoshida, Satoshi Baba, Munehisa Shimamura, Sachiko Okamoto, Yasunori Amaishi, Hideto Chono, Junichi Mineno, Hiromi Rakugi, Ryuichi Morishita, Masahiro Yamamoto, Hironori Nakagami

    Scientific Reports Vol. 12 No. 1 2022/12/03 Research paper (scientific journal)

    Publisher: Springer Science and Business Media LLC
  5. Immune response induced in rodents by anti-CoVid19 plasmid DNA vaccine via pyro-drive jet injector inoculation.

    Tomoyuki Nishikawa, Chin Yang Chang, Jiayu A Tai, Hiroki Hayashi, Jiao Sun, Shiho Torii, Chikako Ono, Yoshiharu Matsuura, Ryoko Ide, Junichi Mineno, Miwa Sasai, Masahiro Yamamoto, Hironori Nakagami, Kunihiko Yamashita

    Immunological medicine p. 1-14 2022/08/24 Research paper (scientific journal)

  6. CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy

    Yi Chun Pan, Tomoyuki Nishikawa, Chin Yang Chang, Jiayu A. Tai, Yasufumi Kaneda

    Molecular Therapy - Oncolytics Vol. 20 p. 175-186 2021/03 Research paper (scientific journal)

    Publisher: Elsevier BV
  7. Correction to: Efficient photodynamic therapy against drug-resistant prostate cancer using replication-deficient virus particles and talaporfin sodium.

    Sharmin Akter, Sachiko Saito, Mizuho Inai, Norihiro Honda, Hisanao Hazama, Tomoyuki Nishikawa, Yasufumi Kaneda, Kunio Awazu

    Lasers in medical science 2020/07/13

  8. Efficient photodynamic therapy against drug-resistant prostate cancer using replication-deficient virus particles and talaporfin sodium.

    Sharmin Akter, Sachiko Saito, Mizuho Inai, Norihiro Honda, Hisanao Hazama, Tomoyuki Nishikawa, Yasufumi Kaneda, Kunio Awazu

    Lasers in medical science 2020/06/27 Research paper (scientific journal)

  9. Cancer immunotherapy using the Fusion gene of Sendai virus.

    Jiayu A Tai, Chin Yang Chang, Tomoyuki Nishikawa, Yasufumi Kaneda

    Cancer gene therapy Vol. 27 No. 6 p. 498-508 2020/06 Research paper (scientific journal)

  10. Photodynamic therapy by lysosomal-targeted drug delivery using talaporfin sodium incorporated into inactivated virus particles.

    Sharmin Akter, Mizuho Inai, Sachiko Saito, Norihiro Honda, Hisanao Hazama, Tomoyuki Nishikawa, Yasufumi Kaneda, Kunio Awazu

    Laser therapy Vol. 28 No. 4 p. 245-256 2019/12/31 Research paper (scientific journal)

  11. Stable Immune Response Induced by Intradermal DNA Vaccination by a Novel Needleless Pyro-Drive Jet Injector.

    Chinyang Chang, Jiao Sun, Hiroki Hayashi, Ayano Suzuki, Yuko Sakaguchi, Hiroshi Miyazaki, Tomoyuki Nishikawa, Hironori Nakagami, Kunihiko Yamashita, Yasufumi Kaneda

    AAPS PharmSciTech Vol. 21 No. 1 p. 19-19 2019/12/09 Research paper (scientific journal)

  12. Highly Selective Photodynamic Therapy with a Short Drug-Light Interval Using a Cytotoxic Photosensitizer Porphyrus Envelope for Drug-Resistant Prostate Cancer Cells

    Youngsoon Hong, Mizuho Inai, Norihiro Honda, Hisanao Hazama, Manjusha A. Joshi, Hiroyuki Nakamura, Tomoyuki Nishikawa, Yasufumi Kaneda, Kunio Awazu

    International Journal of Clinical Medicine Vol. 9 No. 1 p. 8-22 2018/01/11 Research paper (scientific journal)

  13. Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule-1 and enhances natural killer cell sensitivity on cancer cells.

    Simin Li, Tomoyuki Nishikawa, Yasufumi Kaneda

    Cancer science Vol. 108 No. 12 p. 2333-2341 2017/12 Research paper (scientific journal)

  14. Photodynamic therapy using a cytotoxic photosensitizer porphyrus envelope that targets the cell membrane.

    Mizuho Inai, Norihiro Honda, Hisanao Hazama, Sharmin Akter, Shinichiro Fuse, Hiroyuki Nakamura, Tomoyuki Nishikawa, Yasufumi Kaneda, Kunio Awazu

    Photodiagnosis and photodynamic therapy Vol. 20 p. 238-245 2017/12 Research paper (scientific journal)

  15. Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growth.

    Che-Hsin Lee, Tomoyuki Nishikawa, Yasufumi Kaneda

    Oncotarget Vol. 8 No. 21 p. 35048-35060 2017/05/23 Research paper (scientific journal)

  16. Subcellular localization of novel photosensitizer named porphyrus envelope in human prostate cancer cell line PC-3

    Inai Mizuho, Honda Norihiro, Hazama Hisanao, Nakamura Hiroyuki, Yasuda Hidehiro, Nishikawa Tomoyuki, Kaneda Yasufumi, Awazu Kunio

    Nippon Laser Igakkaishi Vol. 37 No. 4 p. 415-420 2017/01 Research paper (scientific journal)

    Publisher: Japan Society for Laser Surgery and Medicine
  17. Virus-stimulated neutrophils in the tumor microenvironment enhance T cell-mediated anti-tumor immunity.

    Chin Yang Chang, Jiayu A Tai, Sumin Li, Tomoyuki Nishikawa, Yasufumi Kaneda

    Oncotarget Vol. 7 No. 27 p. 42195-42207 2016/07/05 Research paper (scientific journal)

  18. Platelet-cytokine Complex Suppresses Tumour Growth by Exploiting Intratumoural Thrombin-dependent Platelet Aggregation.

    Yu-Tung Li, Tomoyuki Nishikawa, Yasufumi Kaneda

    Scientific reports Vol. 6 p. 25077-25077 2016/04/27 Research paper (scientific journal)

  19. An RNA Molecule Derived From Sendai Virus DI Particles Induces Antitumor Immunity and Cancer Cell-selective Apoptosis.

    Li-Wen Liu, Tomoyuki Nishikawa, Yasufumi Kaneda

    Molecular therapy : the journal of the American Society of Gene Therapy Vol. 24 No. 1 p. 135-45 2016/02 Research paper (scientific journal)

  20. Systemic administration of platelets incorporating inactivated Sendai virus eradicates melanoma in mice.

    Tomoyuki Nishikawa, Li Yu Tung, Yasufumi Kaneda

    Molecular therapy : the journal of the American Society of Gene Therapy Vol. 22 No. 12 p. 2046-2055 2014/12 Research paper (scientific journal)

  21. TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles.

    Taeko Matsushima-Miyagi, Koji Hatano, Motonari Nomura, Liu Li-Wen, Tomoyuki Nishikawa, Kotaro Saga, Takashi Shimbo, Yasufumi Kaneda

    Clinical cancer research : an official journal of the American Association for Cancer Research Vol. 18 No. 22 p. 6271-83 2012/11/15 Research paper (scientific journal)

  22. Modification of a novel angiogenic peptide, AG30, for the development of novel therapeutic agents.

    Hironori Nakagami, Tomoyuki Nishikawa, Nao Tamura, Akito Maeda, Hajime Hibino, Masayoshi Mochizuki, Takashi Shimosato, Toshinori Moriya, Ryuichi Morishita, Katsuto Tamai, Kazunori Tomono, Yasufumi Kaneda

    Journal of cellular and molecular medicine Vol. 16 No. 7 p. 1629-39 2012/07 Research paper (scientific journal)

  23. Development of a novel antimicrobial peptide, AG-30, with angiogenic properties.

    Tomoyuki Nishikawa, Hironori Nakagami, Akito Maeda, Ryuichi Morishita, Nobuhiko Miyazaki, Toshihiro Ogawa, Yasuhiko Tabata, Yasushi Kikuchi, Hiroki Hayashi, Yoshiro Tatsu, Noboru Yumoto, Katsuto Tamai, Kazunori Tomono, Yasufumi Kaneda

    Journal of cellular and molecular medicine Vol. 13 No. 3 p. 535-46 2009/03 Research paper (scientific journal)

  24. Identification of angiogenic and antimicrobial factor, AG-30, and analysis of its De Novo engineered variants

    Tomoyuki Nishikawa, Hironori Nakagami, Akito Maeda, Nobuhiko Miyazaki, Yasuhiko Tabata, Ryuichi Morishita, Katsuto Tamai, Yasufumi Kaneda

    JOURNAL OF GENE MEDICINE Vol. 10 No. 4 p. 473-473 2008/04 Research paper (scientific journal)

  25. Cold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response element

    Y. Saito, H. Nakagami, M. Kurooka, Y. Takami, Y. Kikuchi, H. Hayashi, T. Nishikawa, K. Tamai, R. Morishita, N. Azuma, T. Sasajima, Y. Kaneda

    ONCOGENE Vol. 27 No. 13 p. 1821-1833 2008/03 Research paper (scientific journal)

  26. Involvement of gamma-secretase in postnatal angiogenesis.

    Hiroki Hayashi, Hironori Nakagami, Yoichi Takami, Naoyuki Sato, Yukihiro Saito, Tomoyuki Nishikawa, Masaki Mori, Hiroshi Koriyama, Katsuto Tamai, Ryuichi Morishita, Yasufumi Kaneda

    Biochemical and biophysical research communications Vol. 363 No. 3 p. 584-90 2007/11/23 Research paper (scientific journal)

  27. Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation.

    Yoichi Takami, Hironori Nakagami, Ryuichi Morishita, Tomohiro Katsuya, Tai-Xing Cui, Tomonaga Ichikawa, Yukihiro Saito, Hiroki Hayashi, Yasushi Kikuchi, Tomoyuki Nishikawa, Yoshichika Baba, Osamu Yasuda, Hiromi Rakugi, Toshio Ogihara, Yasufumi Kaneda

    Arteriosclerosis, thrombosis, and vascular biology Vol. 27 No. 10 p. 2184-90 2007/10 Research paper (scientific journal)

  28. Effect on vein graft intimal hyperplasia of nuclear factor-kappa B decoy transfection using the second generation of HVJ vector

    N. Shimizu, N. Azuma, T. Nishikawa, S. Hirata, R. Morishita, Y. Kaneda, T. Sasajima

    JOURNAL OF CARDIOVASCULAR SURGERY Vol. 48 No. 4 p. 463-470 2007/08 Research paper (scientific journal)

  29. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.

    Yukihiro Saito, Hironori Nakagami, Ryuichi Morishita, Yoichi Takami, Yasushi Kikuchi, Hiroki Hayashi, Tomoyuki Nishikawa, Katsuto Tamai, Nobuyoshi Azuma, Tadahiro Sasajima, Yasufumi Kaneda

    Circulation Vol. 114 No. 11 p. 1177-84 2006/09/12 Research paper (scientific journal)

  30. Development of high-throughput functional screening of therapeutic genes, using a hemagglutinating virus of Japan envelope vector.

    Tomoyuki Nishikawa, Hironori Nakagami, Atsushi Matsuki, Akito Maeda, Chiah Yian Yo, Taku Harada, Ryuichi Morishita, Katsuto Tamai, Yasufumi Kaneda

    Human gene therapy Vol. 17 No. 4 p. 470-5 2006/04 Research paper (scientific journal)

  31. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells.

    Hironori Nakagami, Kazuhisa Maeda, Ryuichi Morishita, Sota Iguchi, Tomoyuki Nishikawa, Yoichi Takami, Yasushi Kikuchi, Yukihiro Saito, Katsuto Tamai, Toshio Ogihara, Yasufumi Kaneda

    Arteriosclerosis, thrombosis, and vascular biology Vol. 25 No. 12 p. 2542-7 2005/12 Research paper (scientific journal)

  32. Lack of association between the hepatocyte growth factor receptor, c-met, and the anti-apoptotic action of bag-1 in endothelial cells.

    Hironori Nakagami, Ryuichi Morishita, Tomoyuki Nishikawa, Hideo Shimizu, Sota Iguchi, Kunio Matsumoto, Toshikazu Nakamura, Yasufumi Kaneda, Toshio Ogihara

    Hypertension research : official journal of the Japanese Society of Hypertension Vol. 27 No. 5 p. 359-65 2004/05 Research paper (scientific journal)

  33. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system.

    Yasufumi Kaneda, Toshihiro Nakajima, Tomoyuki Nishikawa, Seiji Yamamoto, Hiroyuki Ikegami, Naho Suzuki, Hitomi Nakamura, Ryuichi Morishita, Hitoshi Kotani

    Molecular therapy : the journal of the American Society of Gene Therapy Vol. 6 No. 2 p. 219-26 2002/08 Research paper (scientific journal)

Misc. 12

  1. In Vitro-Synthesized Sendai Virus RNA Fragments Induced Antitumor Immunity and Cancer Cell-Selective Apoptosis

    Tomoyuki Nishikawa, Li-Wen Liu, Yasufumi Kaneda

    MOLECULAR THERAPY Vol. 24 p. S59-S60 2016/05 Research paper, summary (international conference)

  2. Cancer Immunotherapy Using a Cancer-Targeting Platelet Vector Incorporating Viral Particles

    Tomoyuki Nishikawa, Yasufumi Kaneda

    MOLECULAR THERAPY Vol. 22 p. S244-S244 2014/05 Research paper, summary (international conference)

  3. Systemic Administration of Platelet Vector Containing Inactivated Sendai Virus Particle Eradicates Melanoma in Mice

    Tomoyuki Nishikawa, Yasufumi Kaneda

    MOLECULAR THERAPY Vol. 20 p. S264-S264 2012/05 Research paper, summary (international conference)

  4. MODIFICATION OF NOVEL ANGIOGENIC PEPTIDE, AG-30, TOWARD CLINICAL APPLICATION

    Hironori Nakagami, Tomoyuki Nishikawa, Katsuto Tamai, Yasufumi Kaneda

    JOURNAL OF GENE MEDICINE Vol. 12 No. 12 p. 1022-1022 2010/12 Research paper, summary (international conference)

  5. ANALYSIS ON SIGNAL PATHWAY OF AN ANTIMICROBIAL AND ANIGOGENIC PEPTIDE, AG-30, STIMULATED ENDOTHELIAL CELLS

    Tomoyuki Nishikawa, Hironori Nakagami, Ryuichi Morishita, Akito Maeda, Katsuto Tamai, Yasu-fumi Kaneda

    JOURNAL OF GENE MEDICINE Vol. 12 No. 12 p. 1027-1027 2010/12 Research paper, summary (international conference)

  6. ANALYSIS OF DE NOVO ENGINEERED VARIANTS OF AG-30 FOR THE TREATMENT OF ISCHEMIC DISEASES AND INFECTIOUS DISEASES

    Tomoyuki Nishikawa, Hironori Nakagami, Ryuichi Morishita, Akito Maeda, Katsuto Tamai, Kazunori Tomono, Yasufumi Kaneda

    JOURNAL OF GENE MEDICINE Vol. 11 No. 12 p. 1166-1167 2009/12 Research paper, summary (international conference)

  7. Development of high throughput functional screening of cardiovascular therapeutic genes using the HVJ-E vector: Analysis of a novel angiogenic peptide, AG-30

    Tomoyuki Nishikawa, Hironori Nakagami, Katsuto Tamai, Yasufumi Kaneda

    JOURNAL OF GENE MEDICINE Vol. 8 No. 12 p. 1443-1444 2006/12 Research paper, summary (international conference)

  8. gamma-secretase is new therapeutic target for anti-angiogenic therapy

    Hiroki Hayashi, Hironori Nakagami, Yukihiro Saito, Yoichi Talkami, Tomoyuki Nishikawa, Naoyuki Sato, Ryuichi Morishita, Yasufumi Kaneda

    HYPERTENSION Vol. 48 No. 4 p. E94-E94 2006/10 Research paper, summary (international conference)

  9. Development of High Throughput Functional Screening of Cardiovascular Therapeutic Genes Using the HVJ-E Vector

    Tomoyuki Nishikawa, Hironori Nakagami, Atsuhi Matsuki, Yukihiro Saito, Ryuichi Morishita, Katsuto Tamai, Yasufumi Kaneda

    MOLECULAR THERAPY Vol. 13 p. S336-S336 2006/05 Research paper, summary (international conference)

  10. Identification of novel angiogenic peptide, Ag-30

    H Nakagami, T Nishikawa, R Morishita, Y Kaneda

    CIRCULATION Vol. 112 No. 17 p. U256-U256 2005/10 Research paper, summary (international conference)

  11. Development of HVJ-E high throughput gene function screening system: Screening of endothelial cell growth factors

    T Nishikawa, H Nakagami, CY Yo, Y Kaneda

    MOLECULAR THERAPY Vol. 9 p. S113-S114 2004/05 Research paper, summary (international conference)

  12. Prevention of cardiac allograft arteriosclerosis using antisense proliferating-cell nuclear antigen oligonucleotide

    JI Suzuki, M Isobe, R Morishita, T Nishikawa, J Amano, Y Kaneda

    TRANSPLANTATION Vol. 70 No. 2 p. 398-400 2000/07

Industrial Property Rights 4

  1. 免疫賦活用組成物(長鎖:sl-RNA-45-57)

    西川智之, 金田安史, 山下邦彦, 鈴木理乃, 寺居和宏

    出願日:2019/01

  2. 血管新生誘導剤及びそれに用いられるポリペプチド

    中神啓徳, 西川智之, 金田安史

    出願日:2007/02

  3. 新規ポリペプチドおよびそれを有効成分として含有する抗菌剤

    中神啓徳, 西川智之, 金田安史

    出願日:2007/02

  4. 血管内皮細胞増殖促進遺伝子

    中神啓徳, 西川智之, 金田安史

    出願日:2004/03